CA1124952A - Methode et appareil pour la dialyse peritoneale continue ambulatoire - Google Patents

Methode et appareil pour la dialyse peritoneale continue ambulatoire

Info

Publication number: CA1124952A
Authority: CA; Canada
Prior art keywords: patient; bag; tube; fluid; connector
Prior art date: 1977-03-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA297,312A

Other languages

English (en)

Inventor

Robert P. Popovich

Jack W. Moncrief (Sec 33(4)

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

MONCRIEF

Original Assignee

MONCRIEF

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-03-03

Filing date

1978-02-20

Publication date

1982-06-08

1978-02-20 Application filed by MONCRIEF filed Critical MONCRIEF

1982-06-08 Application granted granted Critical

1982-06-08 Publication of CA1124952A publication Critical patent/CA1124952A/fr

Status Expired legal-status Critical Current

Links

238000000502 dialysis Methods 0.000 title claims abstract description 48
238000000034 method Methods 0.000 title abstract description 35
239000012530 fluid Substances 0.000 claims abstract description 57
230000008878 coupling Effects 0.000 claims abstract description 35
238000010168 coupling process Methods 0.000 claims abstract description 35
238000005859 coupling reaction Methods 0.000 claims abstract description 35
210000003200 peritoneal cavity Anatomy 0.000 claims abstract description 22
238000001802 infusion Methods 0.000 claims abstract description 14
210000003815 abdominal wall Anatomy 0.000 claims abstract description 7
210000004303 peritoneum Anatomy 0.000 claims abstract description 6
230000002906 microbiologic effect Effects 0.000 claims abstract description 4
241000894006 Bacteria Species 0.000 claims description 5
238000004891 communication Methods 0.000 claims description 5
230000006854 communication Effects 0.000 claims description 5
230000013011 mating Effects 0.000 claims description 4
230000008569 process Effects 0.000 abstract description 16
239000003053 toxin Substances 0.000 abstract description 6
231100000765 toxin Toxicity 0.000 abstract description 6
108700012359 toxins Proteins 0.000 abstract description 6
231100000331 toxic Toxicity 0.000 abstract description 5
230000002588 toxic effect Effects 0.000 abstract description 5
229920004934 Dacron® Polymers 0.000 abstract description 2
238000009792 diffusion process Methods 0.000 abstract description 2
206010034674 peritonitis Diseases 0.000 abstract description 2
239000005020 polyethylene terephthalate Substances 0.000 abstract description 2
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 22
239000008280 blood Substances 0.000 description 20
210000004369 blood Anatomy 0.000 description 20
108091006146 Channels Proteins 0.000 description 19
239000002207 metabolite Substances 0.000 description 14
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
229940109239 creatinine Drugs 0.000 description 11
238000001631 haemodialysis Methods 0.000 description 11
230000000322 hemodialysis Effects 0.000 description 11
239000000243 solution Substances 0.000 description 11
238000011282 treatment Methods 0.000 description 11
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
210000003734 kidney Anatomy 0.000 description 10
239000004202 carbamide Substances 0.000 description 9
210000004379 membrane Anatomy 0.000 description 8
239000012528 membrane Substances 0.000 description 8
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 6
238000011067 equilibration Methods 0.000 description 6
230000001684 chronic effect Effects 0.000 description 5
230000006870 function Effects 0.000 description 4
230000008901 benefit Effects 0.000 description 3
238000007485 conventional hemodialysis Methods 0.000 description 3
229960002104 cyanocobalamin Drugs 0.000 description 3
235000000639 cyanocobalamin Nutrition 0.000 description 3
239000011666 cyanocobalamin Substances 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
239000002699 waste material Substances 0.000 description 3
208000004998 Abdominal Pain Diseases 0.000 description 2
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
206010047700 Vomiting Diseases 0.000 description 2
230000004075 alteration Effects 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
208000020832 chronic kidney disease Diseases 0.000 description 2
FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
FDJOLVPMNUYSCM-IQFXPAJWSA-L cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahyd Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)OC3C(C(OC3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-IQFXPAJWSA-L 0.000 description 2
230000001627 detrimental effect Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000003792 electrolyte Substances 0.000 description 2
230000014509 gene expression Effects 0.000 description 2
230000024924 glomerular filtration Effects 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000003907 kidney function Effects 0.000 description 2
239000004033 plastic Substances 0.000 description 2
239000000047 product Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000000108 ultra-filtration Methods 0.000 description 2
230000036642 wellbeing Effects 0.000 description 2
206010000060 Abdominal distension Diseases 0.000 description 1
208000009304 Acute Kidney Injury Diseases 0.000 description 1
206010002383 Angina Pectoris Diseases 0.000 description 1
206010003226 Arteriovenous fistula Diseases 0.000 description 1
238000012935 Averaging Methods 0.000 description 1
208000037157 Azotemia Diseases 0.000 description 1
208000012639 Balance disease Diseases 0.000 description 1
208000014644 Brain disease Diseases 0.000 description 1
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
108010010256 Dietary Proteins Proteins 0.000 description 1
102000015781 Dietary Proteins Human genes 0.000 description 1
208000032274 Encephalopathy Diseases 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
206010017807 Gastric mucosal hypertrophy Diseases 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
208000000239 Hypertrophic Gastritis Diseases 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
229920001202 Inulin Polymers 0.000 description 1
206010028813 Nausea Diseases 0.000 description 1
208000031481 Pathologic Constriction Diseases 0.000 description 1
208000001647 Renal Insufficiency Diseases 0.000 description 1
208000033626 Renal failure acute Diseases 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
210000000683 abdominal cavity Anatomy 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
238000002583 angiography Methods 0.000 description 1
230000000578 anorexic effect Effects 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000003143 atherosclerotic effect Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000008499 blood brain barrier function Effects 0.000 description 1
230000036765 blood level Effects 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000001218 blood-brain barrier Anatomy 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
PBAYDYUZOSNJGU-UHFFFAOYSA-N chelidonic acid Natural products OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 1
210000000038 chest Anatomy 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000000332 continued effect Effects 0.000 description 1
208000029078 coronary artery disease Diseases 0.000 description 1
210000004351 coronary vessel Anatomy 0.000 description 1
238000012937 correction Methods 0.000 description 1
230000000875 corresponding effect Effects 0.000 description 1
206010061428 decreased appetite Diseases 0.000 description 1
238000011161 development Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
235000020880 diabetic diet Nutrition 0.000 description 1
239000000385 dialysis solution Substances 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000021245 dietary protein Nutrition 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
239000000806 elastomer Substances 0.000 description 1
208000028208 end stage renal disease Diseases 0.000 description 1
201000000523 end stage renal failure Diseases 0.000 description 1
230000009088 enzymatic function Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229960001031 glucose Drugs 0.000 description 1
230000005484 gravity Effects 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
230000036541 health Effects 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
230000002706 hydrostatic effect Effects 0.000 description 1
239000000819 hypertonic solution Substances 0.000 description 1
229940021223 hypertonic solution Drugs 0.000 description 1
208000006575 hypertriglyceridemia Diseases 0.000 description 1
208000014674 injury Diseases 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
229940029339 inulin Drugs 0.000 description 1
238000011835 investigation Methods 0.000 description 1
201000006370 kidney failure Diseases 0.000 description 1
238000011068 loading method Methods 0.000 description 1
239000006166 lysate Substances 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
229940127554 medical product Drugs 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
230000008693 nausea Effects 0.000 description 1
230000000414 obstructive effect Effects 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
230000037081 physical activity Effects 0.000 description 1
239000011148 porous material Substances 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000003345 scintillation counting Methods 0.000 description 1
229920002379 silicone rubber Polymers 0.000 description 1
208000037804 stenosis Diseases 0.000 description 1
230000036262 stenosis Effects 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000013589 supplement Substances 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
230000008736 traumatic injury Effects 0.000 description 1
229910052722 tritium Inorganic materials 0.000 description 1
208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
229940045136 urea Drugs 0.000 description 1
208000009852 uremia Diseases 0.000 description 1
239000002441 uremic toxin Substances 0.000 description 1
229940116269 uric acid Drugs 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1407—Infusion of two or more substances
- A61M5/1408—Infusion of two or more substances in parallel, e.g. manifolds, sequencing valves
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1672—Apparatus for preparing dialysates using membrane filters, e.g. for sterilising the dialysate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/282—Operational modes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/285—Catheters therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/08—Supports for equipment
- A61M2209/088—Supports for equipment on the body

Landscapes

Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Anesthesiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Vascular Medicine (AREA)
Biophysics (AREA)
Pulmonology (AREA)
External Artificial Organs (AREA)
Separation Using Semi-Permeable Membranes (AREA)

CA297,312A 1977-03-03 1978-02-20 Methode et appareil pour la dialyse peritoneale continue ambulatoire Expired CA1124952A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US77391277A	1977-03-03	1977-03-03
US773,912		1977-03-03

Publications (1)

Publication Number	Publication Date
CA1124952A true CA1124952A (fr)	1982-06-08

Family

ID=25099697

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA297,312A Expired CA1124952A (fr)	1977-03-03	1978-02-20	Methode et appareil pour la dialyse peritoneale continue ambulatoire

Country Status (4)

Country	Link
JP (1)	JPS53108883A (fr)
CA (1)	CA1124952A (fr)
DE (1)	DE2809303A1 (fr)
GB (1)	GB1601223A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2440740A1 (fr) *	1978-11-08	1980-06-06	Abg Semca	Appareil automatique de dialyse peritoneale
FR2455462B1 (fr) *	1979-05-04	1985-09-13	Materiels Annexes Dialyse	Dispositif de dialyse peritoneale
CA1168539A (fr) *	1979-06-04	1984-06-05	Edward M. Goldberg	Methode et appareil pour introduire et retirer des liquides dans un sujet vivant
US4278092A (en) *	1979-07-05	1981-07-14	American Hospital Supply Corporation	Peritoneal catheter
EP0029526A1 (fr) *	1979-11-15	1981-06-03	S.p.a. "S.I.F.RA."	Procédé et dispositif pour dialyse péritonéale
US4311587A (en) *	1979-12-10	1982-01-19	Japan Foundation For Artificial Organs	Filter arrangement denying bacteria entry to peritoneum
US4366816A (en)	1980-12-22	1983-01-04	Abbott Laboratories	Combination quick disconnect coupling and fluid cutoff valve
US4338933A (en)	1980-12-22	1982-07-13	Abbott Laboratories	Combination quick disconnect coupling and liquid cutoff valve
DE3113934A1 (de) *	1981-04-07	1982-10-28	Laboratorien Hausmann AG, 9001 St. Gallen	Vorrichtung zur kontinuierlichen ambulanten peritoneal-dialyse
DE3277521D1 (en) *	1981-11-07	1987-12-03	Laszlo Juhasz	Improved continuous ambulatory peritoneal dialysis system
IT1151884B (it) *	1982-04-16	1986-12-24	Sis Ter Spa	Dispositivo per la dialisi endoperitoneale
US4560472A (en) *	1982-12-10	1985-12-24	Baxter Travenol Laboratories, Inc.	Peritoneal dialysis apparatus
EP0116259A1 (fr) *	1983-02-10	1984-08-22	Laboratorium Dr. G. Bichsel AG	Système de poches et procédé pour mettre en oeuvre la dialyse péritonéale ambulatoire
JPS61185275A (ja) *	1985-02-13	1986-08-18	株式会社　日本メデイカル・サプライ	腹膜透析システム
ATE116136T1 (de) *	1987-03-19	1995-01-15	Fresenius Ag	Beutellose, kontinuierliche, ambulante peritonealdialyse.
EP0314281A1 (fr) *	1987-09-11	1989-05-03	Michael Anthony Belfort	Cathéter
US5041215A (en) *	1989-11-22	1991-08-20	Cobe Laboratories, Inc.	Dialysis unit priming
KR20010072251A (ko)	1998-08-28	2001-07-31	추후제출	자동 호스의 투석 필터
WO2001083001A1 (fr) *	2000-05-02	2001-11-08	Vasca, Inc.	Procedes et dispositifs de drainage de fluides entrant dans, et sortant du corps
JP4379027B2 (ja)	2003-05-14	2009-12-09	株式会社ジェイ・エム・エス	腹膜透析および血液透析併用プランニング方法ならびに腹膜透析および血液透析併用プランニング装置
CN111617331A (zh) *	2019-12-31	2020-09-04	华仁药业股份有限公司	一种医疗用多端口连接器

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3545438A (en) *	1968-02-12	1970-12-08	Sarns Inc	Intermittent dialysis method and apparatus therefor
US3685680A (en) *	1970-06-08	1972-08-22	Battelle Development Corp	Peritoneal dialysis delivery unit using home-prepared dialysate
US3699956A (en) *	1970-10-01	1972-10-24	Tecna Corp	Percutaneous lead device
US3707967A (en) *	1970-10-01	1973-01-02	Tecna Corp	Steady flow regenerative peritoneal dialysis system and method
DE2101168B1 (de) *	1971-01-12	1972-05-25	B. Braun Melsungen AG, 3508 MeIsungen	Dosiersystem für die Peritonealdedialyse

1978
- 1978-02-20 CA CA297,312A patent/CA1124952A/fr not_active Expired
- 1978-02-22 GB GB7141/78A patent/GB1601223A/en not_active Expired
- 1978-03-02 JP JP2402378A patent/JPS53108883A/ja active Pending
- 1978-03-03 DE DE19782809303 patent/DE2809303A1/de not_active Ceased

Also Published As

Publication number	Publication date
DE2809303A1 (de)	1978-10-05
JPS53108883A (en)	1978-09-22
GB1601223A (en)	1981-10-28

Legal Events

Date	Code	Title	Description
1999-06-08	MKEX	Expiry

Publication	Publication Date	Title
US4239041A (en)	1980-12-16	Method for continuous ambulatory peritoneal dialysis
CA1124952A (fr)	1982-06-08	Methode et appareil pour la dialyse peritoneale continue ambulatoire
US6409699B1 (en)	2002-06-25	Continuous flow-through peritoneal dialysis (CFPD) method with control of intraperitoneal pressure
Popovich et al.	1978	Continuous ambulatory peritoneal dialysis
ES2366781T3 (es)	2011-10-25	Sistemas y métodos para la diálisis peritoneal.
JP4460448B2 (ja)	2010-05-12	腹膜透析のためのシステムおよび方法
RU2020970C1 (ru)	1994-10-15	Искусственная почка
EP0714312B1 (fr)	2001-08-29	Appareil pour dialyse peritoneale pulsee purifiee
US10549023B2 (en)	2020-02-04	Universal portable artificial kidney for hemodialysis and peritoneal dialysis
CA2077848C (fr)	2003-05-06	Rein artificiel
EP0928615A1 (fr)	1999-07-14	Methode pour recolter et regenerer le dialysat peritoneal, dispositif et accessoires necessaires
JP2001519211A (ja)	2001-10-23	持続的受動血漿限外濾過による急性および慢性腎疾患治療用器具および方法
JP2003510103A (ja)	2003-03-18	限外濾過浄化および再注入システムを含む血液濾過システム
Lysaght et al.	1989	Membrane phenomena and mass transfer kinetics in peritoneal dialysis
CN2253204Y (zh)	1997-04-30	人工肾透析液再利用装置
David et al.	1995	Predilution hemofiltration. Clinical experience and removal of small molecular weight solutes
Blumenthal et al.	1986	Inflow time and recirculation in single-needle hemodialysis
RU2589658C2 (ru)	2016-07-10	Способ и устройство "симбиотической" гемофильтрации для компенсации хронической почечной недостаточности
Idris et al.	2021	Medical Devices for Nephrology
Rajhans et al.	2017	Design of wearable dialysis unit
JP5995221B6 (ja)	2017-10-25	腹膜透析を実施するためのシステムおよび方法
Di Paolo et al.	1977	Acceleration of peritoneal dialysis with simple device
Binkley	1984	Keeping up with peritoneal dialysis
Friedman	1981	Uremia therapy: Innovations promise near-term improvement
Jungers et al.	1978	Organization of Dialysis Treatment